New Key Statistics Module, Z-Score and F-Score
NAS:INMB Key Ratios
| Market Cap $ M | 109.79 |
| Enterprise Value $ M | 80.89 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.97 |
| Price/Sales | 1,110.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -2.06 |
| Beneish M-Score | -0.65 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -12.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.14 |
| EV-to-EBITDA | -2.14 |
| PEG | -- |
| Shares Outstanding M | 19.78 |
| Net Margin (%) | -44,402.35 |
| Operating Margin % | -44,457.65 |
| Pre-tax Margin (%) | -44,402.35 |
| Quick Ratio | 2.36 |
| Current Ratio | 2.36 |
| ROA % (ttm) | -65.36 |
| ROE % (ttm) | -94.53 |
| ROIC % (ttm) | -144.51 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.53 |
INMB Number of Guru Trades
INMB Volume of Guru Trades
Gurus Latest Trades with NAS:INMB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:INMB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
INmune Bio Inc Insider Transactions
No Available Data
News about NAS:INMB
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers